Kosan BioSciences -- KOSN Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Kosan BioSciences -- KOSN

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mopgcw who wrote (771)	1/6/2007 1:59:46 AM
From: tuck	Read Replies (1) of 933

I'd like to think the incoherence in that piece was due to the AP writer, and that Michael King is much less clueless. Undervalued due to management mistakes . . . well, I've seen worse, really. Kosan is not yet in the class of CTIC, TELK, BLSI. Could have done with less insider selling at this stage. EPO D might not make it, but they got some funds out of Roche before finding out its problems. Am I forgetting/missing other mistakes? "the company should continue to lose money?" Sheesh, I can write better than that drunk. Cheers (Hic), Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next